Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.1525
+0.0015
+(0.99%)
At close: April 3 at 3:18:59 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-20,867
-21,948
-22,557
-19,548
Investing Cash Flow
-15
-48
-163
-459
Financing Cash Flow
12,083
22,155
22,486
20,159
End Cash Position
237
276
117
351
Interest Paid Supplemental Data
642
241
35
--
Capital Expenditure
-50
-48
-163
-459
Issuance of Capital Stock
973
1,668
--
63
Issuance of Debt
12,568
26,506
23,000
20,500
Repayment of Debt
-2,312
-300
-675
-404
Free Cash Flow
-20,917
-21,996
-22,720
-20,007
12/31/2021 - 10/2/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TVGN Tevogen Bio Holdings Inc.
1.0000
-6.54%
SPRC SciSparc Ltd.
0.3004
-0.83%
ZVSA ZyVersa Therapeutics, Inc.
0.6090
+3.69%
PXMD PaxMedica, Inc.
0.0002
0.00%
LIXT Lixte Biotechnology Holdings, Inc.
1.1850
-2.87%
BDRX Biodexa Pharmaceuticals Plc
1.4700
-4.55%
ATXI Avenue Therapeutics, Inc.
0.2710
+3.40%
NLSP NLS Pharmaceutics AG
1.4900
-3.87%
MRSN Mersana Therapeutics, Inc.
0.3061
-9.94%
ERNA Ernexa Therapeutics Inc.
0.1810
-5.24%